ArticleMolecular and clinical oncology2019

CD163 is a predictive biomarker for prognosis of classical Hodgkin's lymphoma in Saudi patients.

Huda Al Sayed Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.